Leif Bjermer

141 – 150 of 374

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/14f9431b-d68a-4ad5-8d0f-d70144c43c56?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
14
15
16
17
…
38
next »

2017
Mark Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD : FLAME-based modelling in a Swedish population
Bjermer, Leif ^LU ; van Boven, Job F.M. ; Costa-Scharplatz, Madlaina ; Keininger, Dorothy L. ; Gutzwiller, Florian S. ; Lisspers, Karin ; Mahon, Ronan ; Olsson, Petter and Roche, Nicolas (2017) In Respiratory Research 18(1).
- Contribution to journal › Article
Mark Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model
Menzel, Mandy ^LU ; Akbarshahi, Hamid ^LU ; Mahmutovic Persson, Irma ^LU ; Puthia, Manoj ^LU ; Bjermer, Leif ^LU and Uller, Lena ^LU (2017) In ERJ Open Research 3(4).
- Contribution to journal › Article
2016
Mark The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study).
Beeh, Kai-Michael ; Derom, Eric ; Echave-Sustaeta, José ; Grönke, Lars ; Hamilton, Alan ; Zhai, Dongmei and Bjermer, Leif ^LU (2016) In The International Journal of Chronic Obstructive Pulmonary Disease 11. p.193-205
- Contribution to journal › Article
Mark Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
Jarenbäck, Linnea ^LU ; Ankerst, Jaro ^LU ; Bjermer, Leif ^LU and Tufvesson, Ellen ^LU (2016) In Respiratory Medicine 110(nov 11). p.28-33
- Contribution to journal › Article
Mark Revisiting the role of the mast cell in asthma.
Andersson, Cecilia ^LU ; Tufvesson, Ellen ^LU ; Diamant, Zuzana ^LU and Bjermer, Leif ^LU (2016) In Current Opinion in Pulmonary Medicine 22(1). p.10-17
- Contribution to journal › Scientific review
Mark Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Bousquet, J. ; Farrell, J. ; Crooks, G. ; Hellings, P. ; Bel, E. H. ; Bewick, M. ; Chavannes, N. H. ; De Sousa, J. Correia ; Cruz, A. A. and Haahtela, T. , et al. (2016) In Clinical and Translational Allergy 6(1). p.1-18
- Contribution to journal › Scientific review
Mark Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies
Singh, Dave ; Gaga, Mina ; Schmidt, Olaf ; Bjermer, Leif ^LU ; Grönke, Lars ; Voß, Florian and Ferguson, Gary T. (2016) In Respiratory Research 17(1).
- Contribution to journal › Article
Mark ARIA 2016 : Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
Bousquet, J. ; Hellings, P. W. ; Agache, I. ; Bedbrook, A. ; Bachert, C. ; Bergmann, K. C. ; Bewick, M. ; Bindslev-Jensen, C. ; Bosnic-Anticevitch, S. and Bucca, C. , et al. (2016) In Clinical and Translational Allergy 6(1).
- Contribution to journal › Scientific review
Mark Azithromycin induces anti-viral effects in cultured bronchial epithelial cells from COPD patients
Menzel, Mandy ^LU ; Akbarshahi, Hamid ^LU ; Bjermer, Leif ^LU and Uller, Lena ^LU (2016) In Scientific Reports 6.
- Contribution to journal › Article
Mark Bronchodilator response of advanced lung function parameters depending on COPD severity
Jarenbäck, Linnea ^LU ; Eriksson, Göran ^LU ; Peterson, Stefan ; Ankerst, Jaro ^LU ; Bjermer, Leif ^LU and Tufvesson, Ellen ^LU (2016) In International Journal of COPD 11(1). p.2939-2950
- Contribution to journal › Article

« previous
1
…
14
15
16
17
…
38
next »